Evaluation with favipiravir in patients with COVID-19. : Efficacy and safety evaluation of Favipiravir for treatment of COVID-19: an adaptive, multicentre, double-blind, randomised, placebo-controlled clinical trial. - SARS-CoV-2 SARS-CoV-2: Severe Acquired Respiratory Syndrome - coronavirus 2

Medienart:

Klinische Studie

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

WHO International Clinical Trials Registry Platform - (2023) vom: 29. Mai Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Links:

Volltext [kostenfrei]

Themen:

610
Medical Condition: Corona virus infection;B97.2
Phase: Phase 2/Phase 3
Recruitment Status: Not yet recruiting
Study Type: Interventional

Anmerkungen:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 29-09-2021, Last updated: 2023-06-05

ICTRP ID:

RBR-85vh8fx

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

WHO007943784